Abstract
The selection of a sperm with good genomic integrity is an important consideration
for improving Intra-Cytoplasmic Sperm Injection (ICSI) outcome. Current convention
selects sperm by vigour and morphology, but preliminary evidence suggests
selection based on hyaluronic acid bidning may be beneficial. The aim of the
HABSelect trial is to determine the efficacy of HA-selection of sperm versus
conventionally selected sperm prior to ICSI on live birth rate (LBR). The mechanistic
aim is to assess whether and how the chromatin state of HA-selected sperm
corresponds with clinical outcomes – clinical pregnancy rate (CPR), LBR and
pregnancy loss (PL).
for improving Intra-Cytoplasmic Sperm Injection (ICSI) outcome. Current convention
selects sperm by vigour and morphology, but preliminary evidence suggests
selection based on hyaluronic acid bidning may be beneficial. The aim of the
HABSelect trial is to determine the efficacy of HA-selection of sperm versus
conventionally selected sperm prior to ICSI on live birth rate (LBR). The mechanistic
aim is to assess whether and how the chromatin state of HA-selected sperm
corresponds with clinical outcomes – clinical pregnancy rate (CPR), LBR and
pregnancy loss (PL).
Original language | English |
---|---|
Article number | e012609 |
Journal | BMJ open |
Volume | 6 |
Issue number | 10 |
DOIs | |
Publication status | Published - 1 Oct 2016 |